[Ketoanalogue diet for advanced chronic kidney failure]
Klappenbach R, García Martí S, Pichon-Riviere A, Augustovski F, García Martí S, Alcaraz A, Bardach A, Ciapponi A.
Record ID 32018001411
Spanish
Authors' recommendations:
CONCLUSIONS
Low-quality evidence on the use of ketoanalogues associated with protein-restricted diets versus standard or less protein-restricted diets for advanced chronic kidney failure is contradictory in terms of its potential risks and benefits; this prevents from drawing conclusions about the efficacy of this technology. There is no evidence assessing the addition of kenoanalogues versus placebo in the same diet regimen.
Most clinical practice guidelines and coverage policies do not mention this technology, although it is worth mentioning that ketoanalogues are not authorized by the United States Food and Drug Administration (FDA).
Details
Project Status:
Completed
Year Published:
2017
URL for published report:
https://www.iecs.org.ar/home-ets/
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Argentina
MeSH Terms
- Renal Insufficiency, Chronic
- Kidney Failure, Chronic
- Diet, Ketogenic
- Caloric Restriction
Contact
Organisation Name:
Institute for Clinical Effectiveness and Health Policy
Contact Address:
Dr. Emilio Ravignani 2024, Buenos Aires - Argentina, C1414 CABA
Contact Name:
info@iecs.org.ar
Contact Email:
info@iecs.org.ar
Copyright:
Institute for Clinical Effectiveness and Health Policy (IECS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.